Drive outcomes with value-based contracting

Brian Solow: Value-based contracting has done quite a dramatic change in how I think we are perceiving the value of medications.

Before, it was about volume. The more volume that you could produce, the more you would prescribe, the more prescriptions written.

But now as we look at value as opposed to volume, that's what we need to move more towards is those true healthy outcomes for the individuals.

And so what you're seeing now is the ability of the life science companies, the payers, the insurers to come together and create outcomes-based contracting.

It's got to be good for the patient, it's got to be good for the payer as well, and good for the life science company.